Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference28 articles.
1. High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice;Saurat;Dermatology,2010
2. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis;Ravindran;Ann Rheum Dis,2008
3. Enbrel [package insert],2011
4. Rheumatrex [package insert],2009
5. Adherence to treatment in patients with psoriasis;Richards;J Eur Acad Dermatol Venereol,2006
Cited by 230 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09
2. Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis;JAMA Dermatology;2024-08-21
3. Oral Psoriasis Therapies;Dermatologic Clinics;2024-07
4. Comparative efficacy and safety of JAK/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis;Indian Journal of Dermatology, Venereology and Leprology;2024-06-03
5. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States;Drug Design, Development and Therapy;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3